Hunan Kelun Pharmaceutical Co., Ltd.

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Safety, Pharmacokinetics, and Pharmacodynamics of Continuous KL0011034 Infusion in Healthy Chinese Adults	General Anesthesia; Healthy Participants Study	Not yet recruiting	Phase 1	2026-09-25	NCT07841626
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects	Healthy Volunteers	Not yet recruiting	Phase 1	2026-09-18	NCT07828470
A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain	Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms	Not yet recruiting	Phase 1	2026-08-07	NCT07751094
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers	Healthy Volunteers	Recruiting	Phase 1	2026-05-27	NCT07474545
Single-dose,First-in-human of KLA478	Healthy Volunteers	Recruiting	Phase 1	2026-05-26	NCT07240675
A Phase I Study of KLA318-2 Nanocrystal Injection	Healthy Participants	Recruiting	Phase 1	2026-05-26	NCT07171034
First-in-Human Single and Multiple Dose of KLA578-1 for Injection	Healthy Volunteers	Recruiting	Phase 1	2026-05-26	NCT07143318

Clinical trials